Latest Asx News

Pantoro Limited delivered a solid December quarter with gold production within guidance and positive cash flows for the fourth consecutive quarter, prompting an upward revision to its FY2025 production target. The company’s strategic focus on underground expansion and asset optimisation underpins its growth trajectory.

HyTerra Limited is set to launch the fully funded exploration phase of its Nemaha Project in Kansas, following a strategic investment from Fortescue Future Industries. The campaign will include leasing, geophysical surveys, and a multi-well drilling program, with operations scheduled to begin once winter conditions ease.

Mighty Kingdom Ltd has appointed Dylan Miklashek as Interim CEO and Duncan Gordon as Non-Executive Chair, signaling a fresh leadership approach amid a company restructuring.

Bell Financial Group has secured a significant agreement with Macquarie Bank to transfer approximately 75,000 online trading accounts, positioning Bell Direct and Desktop Broker for growth and earnings uplift in FY 2025.

Compumedics has locked in a pivotal five-year contract with Philips Australia, cementing Somfit as the leading device for pharmacy-based sleep testing and underpinning significant SaaS revenue growth through 2028.

Amcor plc has entered a definitive agreement to acquire Berry Global Group in a $9.9 billion all-stock transaction, aiming to create a global packaging leader. The merger, pending shareholder and regulatory approvals, is expected to close mid-2025.

Invex Therapeutics reports encouraging results from its collaboration with Tessara Therapeutics, showing Exenatide’s potential to improve neuronal survival in a 3D human brain model of Alzheimer's disease. The company maintains a stable cash position while exploring new neurological partnerships.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

LTR Pharma has inked a national distribution agreement with Symbion, positioning its innovative ED treatment SPONTAN® for broad pharmacy access across Australia ahead of its commercial launch.

Chrysos Corporation reports a robust Q2 FY25 with a 12% quarter-on-quarter and 53% year-on-year revenue increase, driven by expanding international sales and rising sample volumes. The company secured two new contracts, boosting its PhotonAssay™ footprint and maintaining strong financial health.

Copper Search Limited reports promising copper mineralisation at its Douglas Creek IOCG Prospect and outlines plans to expand its project portfolio in 2025 while maintaining a solid cash position.

Zoono Group reports expanding global trials of its shelf-life extension technology, engaging over 40 supermarket and packaging companies, while refining its product and managing cash flow amid cautious commercial adoption.